Sean Cumiskey: From Global Hedge Funds to Saving Lives Through Biotech
Sean Cumiskey shares leaving Farallon partnership for family when wife had breast cancer, taking a year off, growing Yihang from $350M to $3.5B, and finding purpose at Omega Fund Management developing life-saving therapies.










